BMY

Bristol Myers Squibb

Health Care

Pharmaceuticals

New York City, New York

Last filing: Feb 11, 2026 (FY2025)

Account	2025	2024	2023	2022	2021
BS_Assets_Cash	$0	$10.3B	$11.5B	$9.1B	$14.0B
BS_Assets_ShortTermInvest	$0	$513.0M	$816.0M	$1.1B	$2.0B
BS_Assets_AcctsReceivable	$0	$9.0B	$8.9B	$8.2B	$8.0B
BS_Assets_Inventory	$0	$2.6B	$2.7B	$2.3B	$2.1B
BS_Assets_PrepaidExpenses	$0	$5.6B	$5.9B	$5.8B	$4.8B
BS_Assets_PPE	$0	$7.1B	$6.6B	$6.3B	$6.0B
BS_Assets_Goodwill	$36.0M	$21.7B	$21.2B	$21.1B	$20.5B
BS_Assets_IntangibleAssets	$0	$23.3B	$27.1B	$35.9B	$42.5B
BS_Assets_OtherNoncurrent	$0	$6.1B	$5.4B	$4.9B	$5.5B
BS_Liab_AccruedLiab	$0	$2.0B	$2.1B	$2.1B	$1.9B
BS_Liab_OtherNoncurrent	$0	$4.5B	$6.4B	$6.6B	$7.3B
BS_Equity_PreferredStock	$0	$0	$0	$0	$0
BS_Equity_CommonStock	$0	$292.0M	$292.0M	$292.0M	$292.0M
BS_Equity_TreasuryStock	$0	$43.7B	$43.8B	$38.6B	$31.3B
BS_Equity_AOCI	$0	$-1.2B	$-1.5B	$-1.3B	$-1.3B

Account	2025	2024	2023	2022	2021
IS_Revenue_Total	$48.2B	$48.3B	$45.0B	$46.2B	$46.4B
IS_Expense_COGS	$13.9B	$14.0B	$10.7B	$10.1B	$9.9B
IS_Expense_RnD	$10.0B	$11.2B	$9.3B	$9.5B	$10.2B
IS_Expense_SGA	$7.3B	$8.4B	$7.8B	$7.8B	$7.7B
IS_Expense_DA	$4.0B	$9.6B	$9.8B	$10.3B	$10.7B
IS_Expense_SBC	$553.0M	$507.0M	$518.0M	$457.0M	$583.0M
IS_Expense_Restructuring	$563.0M	$635.0M	$365.0M	$75.0M	$169.0M
IS_Expense_TotalOpex	$38.9B	$56.7B	$36.6B	$38.4B	$38.3B
IS_OperatingIncome	$7.1B	$-8.9B	$8.0B	$6.3B	$7.0B
IS_InterestIncome	$586.0M	$478.0M	$449.0M	$171.0M	$39.0M
IS_InterestExpense	$1.9B	$1.9B	$1.2B	$1.2B	$1.3B
IS_OtherNonopIncExp	$-674.0M	$-893.0M	$1.2B	$-576.0M	$720.0M
IS_PreTaxIncome	$9.3B	$-8.4B	$8.4B	$7.7B	$8.1B
IS_TaxExpense	$2.3B	$554.0M	$400.0M	$1.4B	$1.1B
IS_NetIncome	$7.1B	$-8.9B	$8.0B	$6.3B	$7.0B
IS_ComprehensiveIncome	$6.8B	$-8.6B	$7.8B	$6.3B	$7.6B
IS_EPS_Basic	$3	$-4	$4	$3	$3
IS_EPS_Diluted	$3	$-4	$4	$3	$3
IS_Shares_Basic	$2.0B	$2.0B	$2.1B	$2.1B	$2.2B
IS_Shares_Diluted	$2.0B	$2.0B	$2.1B	$2.1B	$2.2B

Account	2025	2024	2023	2022	2021
CF_Ops_NetIncome	$7.1B	$-8.9B	$8.0B	$6.3B	$7.0B
CF_Ops_DA	$4.0B	$9.6B	$9.8B	$10.3B	$10.7B
CF_Ops_SBC	$553.0M	$507.0M	$518.0M	$457.0M	$583.0M
CF_Ops_DeferredTax	$-965.0M	$-2.1B	$-3.3B	$-2.7B	$-1.4B
CF_Ops_WorkingCapital	$182.0M	$670.0M	$949.0M	$178.0M	$232.0M
CF_Ops_NetCash	$14.2B	$15.2B	$13.9B	$13.1B	$16.2B
CF_Inv_Capex	$1.3B	$1.2B	$1.2B	$1.1B	$973.0M
CF_Inv_Acquisitions	$3.9B	$21.8B	$1.2B	$4.3B	$1.6B
CF_Inv_PurchaseInvestments	$2.0B	$769.0M	$1.8B	$3.6B	$5.5B
CF_Inv_NetCash	$-4.1B	$-21.4B	$-2.3B	$-1.1B	$-538.0M
CF_Fin_DebtIssuance	$5.7B	$12.9B	$4.5B	$5.9B	$0
CF_Fin_DebtRepayment	$10.9B	$2.9B	$3.9B	$11.4B	$6.0B
CF_Fin_ShareRepurchases	$0	$0	$5.2B	$8.0B	$6.3B
CF_Fin_Dividends	$5.0B	$4.9B	$4.7B	$4.6B	$4.4B
CF_Fin_Other	$558.0M	$520.0M	$27.0M	$984.0M	$641.0M
CF_Fin_NetCash	$-10.3B	$5.1B	$-9.4B	$-17.0B	$-16.2B
CF_FX_Effect	$195.0M	$-137.0M	$45.0M	$-33.0M	$-102.0M
CF_Net_Change	$-129.0M	$-1.2B	$2.2B	$-5.0B	$-657.0M

Stock price history for BMY hasn't been loaded yet.